Pharmacotherapy for the Obese Patient
| Autor: | Peter J. Carek, Lori M. Dickerson |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
medicine.medical_specialty
business.industry Body Mass Index Discontinuation Orlistat Regimen Adrenergic Agents Serotonin Agents Anti-Obesity Agents Endocrinology Pharmacotherapy Weight loss Internal medicine Appetite Depressants medicine Humans Pharmacology (medical) Obesity medicine.symptom Intensive care medicine business Weight gain medicine.drug Sibutramine |
| Zdroj: | Primary Care: Clinics in Office Practice. 36:407-415 |
| ISSN: | 0095-4543 |
| DOI: | 10.1016/j.pop.2009.01.004 |
| Popis: | The long-term safety of many antiobesity pharmacologic regimens has not been adequately evaluated. If recommended and prescribed, pharmacologic agents should be an adjunct to a structured diet and exercise regimen. Unfortunately, weight gain after discontinuation of antiobesity agents is common. In addition, the effect of weight loss obtained through the use of pharmacotherapeutic agents on overall morbidity and mortality has not been established. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|